in contrast , infusion of saralasin at 0.01 microgram.kg-1.min-1 did not affect the change in renal blood flow produced by ang ii , indicating that at this dosage the antagonist did not leave the mesenteric circulation in pharmacologically significant quantities .
C0036193
saralasin
C0003009
ang ii